P154 Population pharmacokinetic (POP-PK) model is useful to optimise tobramycin dosage in cystic fibrosis patients L. Darnaud,M. Mittaine,M. Murris, H. Guet-Revillet,P. GandiaJournal of Cystic Fibrosis（2020）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
